UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease

Journal of enzyme inhibition and medicinal chemistry, 2023-12, Vol.38 (1), p.2175821-2175821

2023

Volltextzugriff (PDF)

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer

Molecules (Basel, Switzerland), 2023-01, Vol.28 (2), p.840

2023

Volltextzugriff (PDF)

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

Pharmaceuticals (Basel, Switzerland), 2023-09, Vol.16 (9), p.1266

2023

Volltextzugriff (PDF)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency

Molecules (Basel, Switzerland), 2021-02, Vol.26 (4), p.1001

2021

Volltextzugriff (PDF)

N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

Cancers, 2024-06, Vol.16 (11), p.2033

2024

Volltextzugriff (PDF)

Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs

International journal of molecular sciences, 2021-11, Vol.22 (22), p.12575

2021

Volltextzugriff (PDF)

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Molecular cancer therapeutics, 2009-12, Vol.8 (12), p.3331-3340

2009

Volltextzugriff (PDF)

Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors

Pharmaceuticals (Basel, Switzerland), 2022-05, Vol.15 (5), p.632

2022

Volltextzugriff (PDF)

An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Acta pharmaceutica Sinica. B, 2021-09, Vol.11 (9), p.2694-2708

2021

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

Bioorganic & medicinal chemistry, 2009-08, Vol.17 (16), p.5974-5982

2009

Volltextzugriff (PDF)

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors

Pharmaceuticals (Basel, Switzerland), 2022-06, Vol.15 (7), p.778

2022

Volltextzugriff (PDF)

Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors

Pharmaceuticals (Basel, Switzerland), 2021-03, Vol.14 (4), p.292

2021

Volltextzugriff (PDF)

Structure–Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents

ACS omega, 2023-07, Vol.8 (29), p.25903-25923

2023

Volltextzugriff (PDF)

Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties

European journal of medicinal chemistry, 2019-10, Vol.180, p.154-170

2019

Volltextzugriff (PDF)

Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins

Journal of medicinal chemistry, 2017-07, Vol.60 (13), p.5377-5391

2017

Volltextzugriff (PDF)

Design and Synthesis of Novel Phenylpiperazine Derivatives as Potential Anticonvulsant Agents

Archiv der Pharmazie (Weinheim), 2015-12, Vol.348 (12), p.868-874

2015

Volltextzugriff (PDF)

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach

European journal of medicinal chemistry, 2010-01, Vol.45 (1), p.90-97

2010

Volltextzugriff (PDF)

An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications

Medicinal research reviews, 2023-03, Vol.43 (2), p.343-398

2023

Volltextzugriff (PDF)

Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds

ACS omega, 2019-07, Vol.4 (7), p.11440-11454

2019

Volltextzugriff (PDF)

Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects

European journal of medicinal chemistry, 2022-01, Vol.227, p.113911, Article 113911

2022

Volltextzugriff (PDF)

First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents

Journal of medicinal chemistry, 2017-04, Vol.60 (7), p.2853-2868

2017

Volltextzugriff (PDF)

Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity

European journal of medicinal chemistry, 2023-02, Vol.247, p.115019-115019, Article 115019

2023

Volltextzugriff (PDF)

Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker

European journal of medicinal chemistry, 2022-08, Vol.238, p.114411-114411, Article 114411

2022

Volltextzugriff (PDF)

Synthesis and evaluation of novel N1-acylated 5-(4-pyridinyl)indazole derivatives as potent and selective haspin inhibitors

Bioorganic chemistry, 2024-04, Vol.145, p.107235-107235, Article 107235

2024

Volltextzugriff (PDF)

N 1 -Benzoylated 5-(4-pyridinyl)indazole-based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents

Archiv der Pharmazie (Weinheim), 2024-06, Vol.357 (6), p.e2400020

2024

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(134)
Buchkapitel
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency

N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors

An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors

Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors

Structure–Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents

Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties

Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins

Design and Synthesis of Novel Phenylpiperazine Derivatives as Potential Anticonvulsant Agents

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach

An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications

Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds

Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects

First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents

Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity

Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker

Synthesis and evaluation of novel N1-acylated 5-(4-pyridinyl)indazole derivatives as potent and selective haspin inhibitors

N 1 -Benzoylated 5-(4-pyridinyl)indazole-based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents

Suchergebnisse filtern